The changing treatment landscape for MDR/XDR-TB — Can current clinical trials revolutionise and inform a brave new world?
Author:
Funder
European and Developing Countries Clinical Trials Partnership
Publisher
Elsevier BV
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference27 articles.
1. Multidrug resistant pulmonary tuberculosis treatment regimens and patient outcomes: an individual patient data meta-analysis of 9,153 patients;Ahuja;PLoS Med,2012
2. Rapid molecular detection of tuberculosis and rifampin resistance;Boehme;N Engl J Med,2010
3. PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis;Coleman;Sci Transl Med,2014
4. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis;Collaborative Group for the Meta-Analysis of Individual Patient Data in MDRTBt;Lancet,2018
5. The Nix-TB trial of pretomanid, bedaquiline and linezolid to treat XDR-TB;Conradie,2017
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Single‐cell sequencing: Current applications in various tuberculosis specimen types;Cell Proliferation;2024-07-02
2. Unraveling Dilemmas and Lacunae in the Escalating Drug Resistance of Mycobacterium tuberculosis to Bedaquiline, Delamanid, and Pretomanid;Journal of Medicinal Chemistry;2024-02-14
3. Structural Insights into the Penicillin-Binding Protein 4 (DacB) from Mycobacterium tuberculosis;International Journal of Molecular Sciences;2024-01-12
4. Synthesis, characterization, in vitro antimycobacterial and cytotoxicity evaluation, DFT calculations, molecular docking and ADME studies of new isomeric benzimidazole-1,2,3-triazole-quinoline hybrid mixtures;Bioorganic Chemistry;2023-12
5. Short and Efficient Synthesis of the Antituberculosis Agent Pretomanid from (R)-Glycidol;Organic Process Research & Development;2023-09-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3